CN101744054A - Infant formula milk powder - Google Patents
Infant formula milk powder Download PDFInfo
- Publication number
- CN101744054A CN101744054A CN201010000824A CN201010000824A CN101744054A CN 101744054 A CN101744054 A CN 101744054A CN 201010000824 A CN201010000824 A CN 201010000824A CN 201010000824 A CN201010000824 A CN 201010000824A CN 101744054 A CN101744054 A CN 101744054A
- Authority
- CN
- China
- Prior art keywords
- milk
- milk powder
- addition
- formula milk
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 title claims abstract description 54
- 235000013336 milk Nutrition 0.000 title claims abstract description 52
- 239000008267 milk Substances 0.000 title claims abstract description 52
- 210000004080 milk Anatomy 0.000 title claims abstract description 52
- 235000013350 formula milk Nutrition 0.000 title claims abstract description 35
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 66
- 102000007544 Whey Proteins Human genes 0.000 claims abstract description 46
- 108010046377 Whey Proteins Proteins 0.000 claims abstract description 46
- 108010035532 Collagen Proteins 0.000 claims abstract description 26
- 102000008186 Collagen Human genes 0.000 claims abstract description 26
- 229920001436 collagen Polymers 0.000 claims abstract description 26
- 239000005862 Whey Substances 0.000 claims abstract description 16
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 16
- 239000002366 mineral element Substances 0.000 claims abstract description 13
- 235000016709 nutrition Nutrition 0.000 claims abstract description 10
- 229940088594 vitamin Drugs 0.000 claims abstract description 7
- 229930003231 vitamin Natural products 0.000 claims abstract description 7
- 235000013343 vitamin Nutrition 0.000 claims abstract description 7
- 239000011782 vitamin Substances 0.000 claims abstract description 7
- 235000018102 proteins Nutrition 0.000 claims abstract description 5
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 5
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 5
- 235000008452 baby food Nutrition 0.000 claims abstract description 3
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 3
- 235000014633 carbohydrates Nutrition 0.000 claims abstract description 3
- 239000005018 casein Substances 0.000 claims abstract description 3
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims abstract description 3
- 235000021240 caseins Nutrition 0.000 claims abstract description 3
- 235000019197 fats Nutrition 0.000 claims abstract description 3
- 235000021119 whey protein Nutrition 0.000 claims description 30
- 239000004480 active ingredient Substances 0.000 claims description 24
- 239000000047 product Substances 0.000 claims description 23
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 22
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims description 20
- 150000003271 galactooligosaccharides Chemical class 0.000 claims description 20
- 239000003921 oil Substances 0.000 claims description 16
- 235000019198 oils Nutrition 0.000 claims description 16
- 102000010445 Lactoferrin Human genes 0.000 claims description 15
- 108010063045 Lactoferrin Proteins 0.000 claims description 15
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 claims description 15
- 229940078795 lactoferrin Drugs 0.000 claims description 15
- 235000021242 lactoferrin Nutrition 0.000 claims description 15
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims description 13
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims description 13
- 229960001231 choline Drugs 0.000 claims description 13
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims description 13
- 229960000367 inositol Drugs 0.000 claims description 13
- 229960005375 lutein Drugs 0.000 claims description 13
- 235000012680 lutein Nutrition 0.000 claims description 13
- 239000001656 lutein Substances 0.000 claims description 13
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 claims description 13
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 claims description 13
- 239000002773 nucleotide Substances 0.000 claims description 13
- 125000003729 nucleotide group Chemical group 0.000 claims description 13
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims description 13
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 claims description 13
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 claims description 13
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 claims description 11
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 claims description 11
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 11
- 239000008101 lactose Substances 0.000 claims description 11
- 229940083466 soybean lecithin Drugs 0.000 claims description 11
- 229960003080 taurine Drugs 0.000 claims description 11
- 102000004407 Lactalbumin Human genes 0.000 claims description 9
- 108090000942 Lactalbumin Proteins 0.000 claims description 9
- 230000000694 effects Effects 0.000 claims description 9
- 239000012141 concentrate Substances 0.000 claims description 8
- 239000011265 semifinished product Substances 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 8
- 230000037396 body weight Effects 0.000 claims description 6
- 238000001704 evaporation Methods 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 6
- 230000001954 sterilising effect Effects 0.000 claims description 6
- 238000004659 sterilization and disinfection Methods 0.000 claims description 6
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 235000014121 butter Nutrition 0.000 claims description 5
- 238000002372 labelling Methods 0.000 claims description 5
- 230000033228 biological regulation Effects 0.000 claims description 4
- 235000020247 cow milk Nutrition 0.000 claims description 4
- 238000004090 dissolution Methods 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 4
- 239000012535 impurity Substances 0.000 claims description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 4
- 150000004667 medium chain fatty acids Chemical class 0.000 claims description 4
- 239000011707 mineral Substances 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 235000020185 raw untreated milk Nutrition 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 3
- 239000008158 vegetable oil Substances 0.000 claims description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 2
- 206010012735 Diarrhoea Diseases 0.000 claims description 2
- GRSZFWQUAKGDAV-KQYNXXCUSA-N IMP Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(O)=O)O[C@H]1N1C(NC=NC2=O)=C2N=C1 GRSZFWQUAKGDAV-KQYNXXCUSA-N 0.000 claims description 2
- 102000014171 Milk Proteins Human genes 0.000 claims description 2
- 108010011756 Milk Proteins Proteins 0.000 claims description 2
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 claims description 2
- 229950006790 adenosine phosphate Drugs 0.000 claims description 2
- 210000000577 adipose tissue Anatomy 0.000 claims description 2
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims description 2
- 230000001580 bacterial effect Effects 0.000 claims description 2
- 244000052616 bacterial pathogen Species 0.000 claims description 2
- 235000013734 beta-carotene Nutrition 0.000 claims description 2
- 239000011648 beta-carotene Substances 0.000 claims description 2
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims description 2
- 229960002747 betacarotene Drugs 0.000 claims description 2
- 230000003115 biocidal effect Effects 0.000 claims description 2
- 210000000481 breast Anatomy 0.000 claims description 2
- 239000003240 coconut oil Substances 0.000 claims description 2
- 235000019864 coconut oil Nutrition 0.000 claims description 2
- 239000002131 composite material Substances 0.000 claims description 2
- 238000001816 cooling Methods 0.000 claims description 2
- 235000005687 corn oil Nutrition 0.000 claims description 2
- 239000002285 corn oil Substances 0.000 claims description 2
- IERHLVCPSMICTF-XVFCMESISA-N cytidine 5'-monophosphate Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(O)=O)O1 IERHLVCPSMICTF-XVFCMESISA-N 0.000 claims description 2
- IERHLVCPSMICTF-UHFFFAOYSA-N cytidine monophosphate Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(COP(O)(O)=O)O1 IERHLVCPSMICTF-UHFFFAOYSA-N 0.000 claims description 2
- 239000000428 dust Substances 0.000 claims description 2
- 230000008020 evaporation Effects 0.000 claims description 2
- 239000012530 fluid Substances 0.000 claims description 2
- 229960001375 lactose Drugs 0.000 claims description 2
- 239000000463 material Substances 0.000 claims description 2
- 244000005700 microbiome Species 0.000 claims description 2
- 230000000116 mitigating effect Effects 0.000 claims description 2
- 239000000575 pesticide Substances 0.000 claims description 2
- 235000013406 prebiotics Nutrition 0.000 claims description 2
- 239000002994 raw material Substances 0.000 claims description 2
- 238000005057 refrigeration Methods 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- 238000005507 spraying Methods 0.000 claims description 2
- 238000003860 storage Methods 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims description 2
- DJJCXFVJDGTHFX-XVFCMESISA-N uridine 5'-monophosphate Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(O)=O)O[C@H]1N1C(=O)NC(=O)C=C1 DJJCXFVJDGTHFX-XVFCMESISA-N 0.000 claims description 2
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 claims 1
- RQFCJASXJCIDSX-UHFFFAOYSA-N 14C-Guanosin-5'-monophosphat Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(COP(O)(O)=O)C(O)C1O RQFCJASXJCIDSX-UHFFFAOYSA-N 0.000 claims 1
- 244000068988 Glycine max Species 0.000 claims 1
- 235000010469 Glycine max Nutrition 0.000 claims 1
- 240000008415 Lactuca sativa Species 0.000 claims 1
- 235000019486 Sunflower oil Nutrition 0.000 claims 1
- RQFCJASXJCIDSX-UUOKFMHZSA-N guanosine 5'-monophosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O RQFCJASXJCIDSX-UUOKFMHZSA-N 0.000 claims 1
- 235000012045 salad Nutrition 0.000 claims 1
- 239000002600 sunflower oil Substances 0.000 claims 1
- 230000006870 function Effects 0.000 abstract description 8
- 230000036039 immunity Effects 0.000 abstract description 6
- 230000001079 digestive effect Effects 0.000 abstract description 4
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 210000000653 nervous system Anatomy 0.000 abstract description 3
- 230000035764 nutrition Effects 0.000 abstract description 3
- 210000004347 intestinal mucosa Anatomy 0.000 abstract description 2
- 208000035240 Disease Resistance Diseases 0.000 abstract 1
- 108010001441 Phosphopeptides Proteins 0.000 abstract 1
- 239000000470 constituent Substances 0.000 abstract 1
- 230000035755 proliferation Effects 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 18
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 18
- 150000001875 compounds Chemical class 0.000 description 11
- 241000234295 Musa Species 0.000 description 10
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 10
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 9
- 229940114079 arachidonic acid Drugs 0.000 description 9
- 235000021342 arachidonic acid Nutrition 0.000 description 9
- 229960000304 folic acid Drugs 0.000 description 9
- 235000019152 folic acid Nutrition 0.000 description 9
- 239000011724 folic acid Substances 0.000 description 9
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- 239000008103 glucose Substances 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 5
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
- 239000011575 calcium Substances 0.000 description 4
- 229910052791 calcium Inorganic materials 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 210000003754 fetus Anatomy 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000037182 bone density Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 210000000813 small intestine Anatomy 0.000 description 3
- NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 1
- MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 description 1
- NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 description 1
- 208000036818 High risk pregnancy Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 208000036029 Uterine contractions during pregnancy Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- LFVGISIMTYGQHF-UHFFFAOYSA-N ammonium dihydrogen phosphate Chemical compound [NH4+].OP(O)([O-])=O LFVGISIMTYGQHF-UHFFFAOYSA-N 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 229940029575 guanosine Drugs 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 229940088592 immunologic factor Drugs 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000008271 nervous system development Effects 0.000 description 1
- 235000015816 nutrient absorption Nutrition 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000001020 rhythmical effect Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000008467 tissue growth Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
Landscapes
- Dairy Products (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The invention relates to infant formula milk powder and a production method thereof. The infant formula milk powder contains nutrition constituents such as protein, fat, carbohydrate, vitamins, mineral elements and the like with content regulated by the national standards on infant foods. Moreover, whey peptides, collagen peptides and casein phosphopeptides are added in the milk powder. Since the three kinds of binding peptides are added, the invention has the advantages that the immunity of cesarean infants is improved and the disease resistance of the infants is enhanced; the digestive function of the infants is improved, the intestinal mucosa proliferation is promoted and the digestive function is improved; and the development of the nervous system is promoted, the nutrition supply to the nervous system is guaranteed and the memory and the learning ability of the infants are improved.
Description
One, technical field
The present invention relates to a kind of baby formula milk powder prescription and production method thereof, specifically is the baby formula milk powder and the production method thereof of adding whey protein peptide, collagen peptide and three kinds of combined activity peptides of CPP about a kind of.
Two, background technology
Cut open the palace produce be solve difficult labour and severe high risk pregnancy, reach under the situation such as high risk fetus terminal pregnancy the most quick, the most effective way.Along with development of science and technology and cut open the improvement day by day of palace product technology, caesarean delivered security obtains popular approval gradually.In addition, because people are in order to reduce pain, the renewal of various ideas, and be subjected to the women to pursue factor affecting such as pretty figure, select caesarean delivered number to be obvious ascendant trend in recent years.
Fetus is in special environment in the spontaneous labor process, a series of processes such as change through uterine contraction, birth canal tension force, health, chest abdomen and other positions can be subjected to rhythmical extruding, this stimulation is of value to the discharge of gas in the fetus air flue, more is of value to various sensory informations and carries out efficient combination in the fetus central nervous system.Do not have through this a series of process and cut open the newborn baby, compare with the natural labor youngster that to cut open in newborn baby's body immune factor content lower, immunity is obviously low, and the integration harmony of various sensations is relatively poor.Part is cutd open the newborn baby obstacles such as poor location, difficult concentrating, hyperactivity, exercise not harmony, sense of movement be bad may occur in the future.
At present, the baby formula milk powder that the market is designed at cuing open newborn baby's special physiological specially is less, adds the active function Toplink and helps to cut open the newborn baby and overcome multiple physiological defect, and the development of China's infantile health cause is significant.
Three, summary of the invention
The object of the present invention is to provide a kind of baby formula milk powder that contains the various active Functional Polypeptides, product not only can satisfy general baby's nutritional need, and the peptide nutrient that adds helps cuing open newborn baby's immunity, systems such as nerve improve with sound, promote to grow, strengthen bone density.
Concrete technical scheme: a kind of baby formula milk powder, contain the nutritional labeling such as protein, fat, carbohydrate, vitamin, mineral element of infant food national standard defined content in this formula milk, it is characterized in that: also added whey protein peptide, collagen peptide and three kinds of active peptides of CPP in this milk powder.
The lactalbumin Toplink of being added in the above-mentioned formula milk promotes to grow, and strengthens bone density, strengthens immunity, improves learning memory.The collagen Toplink of adding promotes tissue repair.CPP can promote the absorption of body to calcium, iron.According to the best auxiliaring effect of whey protein peptide feeding trial result and collagen peptide: determine the optimum addition of 0-6 1 section (body weight 3.14-7.27Kg) whey protein peptide of month baby and collagen peptide active ingredient is respectively 2.31Kg/ ton and 1.04Kg/ ton; 6-12 month optimum addition than big 2 sections (body weight 7.77-8.69Kg) whey protein peptides of baby and collagen peptide active ingredient is respectively 2.77Kg/ ton and 1.24Kg/ ton; Optimum addition to 3 sections (body weight 11.46-13.21Kg) whey protein peptides of 1-3 one full year of life child and collagen peptide active ingredient is respectively 5.62Kg/ ton and 2.53Kg/ ton; CPP determines that according to regulation and three kinds of combined peptide composite effects of GB2760 best auxiliary addition is 0.198g/100g.
Contain in the formula for a product milk powder and can help infant's body fat to digest and assimilate, diarrhoea is had the medium chain fatty acid of mitigation, medium chain fatty acid content accounts for about 7.9% of TFA.The recommendation guide of setting up with reference to food industry associations of European Union special dietary application device (IDACE) designs.
Contain in the above-mentioned formula milk that lactalbumin and casein ratio are 6: 4 in the protein, according to lactalbumin in the breast milk composition and the design of caseic ratio.Lactalbumin derives from nonreactive fresh milk, desalted whey powder, WPC or sepg whey albumen.
All according to the balanced design of the relevant regulation of country, it is required to satisfy each stage infant health fully for content in the above-mentioned formula milk in the kind of vitamin and mineral element and the every 100kcal heat product.In the formula milk there be the nutritional labeling of selected interpolation: combination of prebiotics FOS and galactooligosaccharide addition are 1g/100g, and soybean lecithin content is 0.2g/100g, and DHA and ARA addition are 20mg/100g.The choline addition is 75mg/100g in the infant formula; the taurine addition is 39mg/100g, and the inositol addition is 23mg/100g, and L-carnitine addition is 10mg/100g; the lutein addition is 0.18mg/100g, and the beta carotene addition is 0.15mg/100g.
Lactoferrin and nucleotides have been added in the above-mentioned prescription.Lactoferrin is 30mg/100g; Kind and proportioning that nucleotides adds are cytidine 5 '-phosphate: adenosine 5 '-phosphate: uridine 5 '-phosphate: guanosine: 5 '-phosphate: inosine 5 '-phosphate=2: 1: 1: 1: 1.
But the compound special oil of love fourth that adds in the above-mentioned formula powder can be one or more the combination in soybean oil, coconut oil, corn oil, rapeseed oil and the palm oil, and this product has also added anhydrous butter oil.
Banaina, apple end have been added in the above-mentioned formula powder.Protein content is higher in the banaina, and vitamin, mineral matter are also very abundant, and heat also occupies high in fruit, and is rich in potassium, but the ill-effect of sodium in the banaina balance infants, and promote cell and tissue growth.Can promote baby's enterogastric peristalsis with the banana end, promote absorption of nutrient ingredients, prevent constipation.
The peptide compound that to be two or more amino acid link to each other with peptide bond is between macro-molecular protein and amino acid one section a kind of nutritional labeling that tool activity, the easiest absorption, physiological function are tired.Whey protein peptide, three kinds of combined peptides of collagen peptide and CPP need not digest, and can directly be absorbed by the body.It directly enters small intestine with complete form, enters the human recycle system, and three kinds of combined peptides can help to cut open the newborn baby and improve immunity by auxilliary mutually function, promote nutrient absorption, and tachyauxesis improves memory.
This product adopts fluidized bed agglomeration redrying technology leading in the world to machine, and preferred processing step is as follows:
1) fresh milk is checked and accepted:
Detect as acidity, proportion, taste smell, mingle etc. at every index that may influence product quality, contain harmful substance such as residues of pesticides, antibiotic etc. in the strict control milk human body.
2) raw milk preliminary treatment:
Cow's milk is removed bigger foreign matter, impurity through the coarse filtration of filter, then 6500 rev/mins down through the processing of centrifugal milk clarifiers, remove tiny dust, big bacterial body, body cell etc., make its impurity degree≤0.5mg/Kg, improve the quality of products.Laggard column criterionization makes its composition stable homogeneous, and after chip refrigeration makes the raw material cooling storage temperature smaller or equal to 4 ℃.
3) preheating sterilization:
Raw milk is clung to formula sterilization 15-30 second under 73-80 ℃, to reach kill pathogenic bacteria and most of microorganism, improve the purposes such as heat endurance of cow's milk protein.
4) batching:
Milk after the preheating sterilization is pumped into material-compound tank, except that some vegetable oil and other material dissolution homogeneous that is difficult for mixing are added the material-compound tank, with whey protein peptide, collagen peptide and CPP pump into mixing tank 50-60 ℃ of dissolving down after homogeneous under the 150-180MPa pressure is complete.
With about 45 ℃ water and PURE WHEY, lactose, lactoferrin, choline, inositol, lutein add material-compound tank after restoring evenly.
With small powders such as the abundant dissolution of minerals salt of 30-50 ℃ water, stir, pour the semi-finished product cylinder after the filtration slowly into, the semi-finished product cylinder must not stop when milk is arranged stirring.
Fully dissolve small powders such as vitamin with 30-50 ℃ water, stir, pour the semi-finished product cylinder after the filtration slowly into, the semi-finished product cylinder must not stop when milk is arranged stirring.
5) vacuum concentrates:
Adopt the triple effect evaporation vacuum to concentrate, one imitates vacuum pressure 0.06MPa, and evaporating temperature is 68-72 ℃; Two imitate vacuum 0.08-0.09MPa, triple effect vacuum 0.08-0.09MPa, evaporating temperature 45-50 ℃; After vacuum concentrates, increase the milk powder granularity, improve the milk powder wettable.
6) spraying and dry:
Concentrate breast and be dispersed into tiny vaporific droplet through atomizer in drying tower, tiny droplet mixes (EAT 170-195 ℃) with hot-air, and moisture moment is evaporated, and is discharged by exhaust blower, and temperature of outgoing air 75-90 ℃, the interior negative pressure 5mmH of tower
2About Oh, adopt fluid bed to fail powder and two-stage drying at last.
Whey protein peptide, collagen peptide, CPP are three kinds of active function peptides.Whey protein peptide has the peptide nutrient and easily absorbs general character such as high strength bioactive and unique physiological function.The lactalbumin Toplink promotes to grow, strengthen bone density, strengthens immunity, improves learning and memory.Lactalbumin has also obtained many very polypeptide of high bioactivity that have through enzymolysis, these lactalbumin enzymolysis peptides have shown different functions with external in vivo, as anti-hypertension, hypoglycemic, anti-oxidant, antithrombotic, immunological regulation, the absorption of promotion mineral matter etc.Collagen peptide has unique filamentary structure and excellent biological compatibility, degradability and low antigenicity, and it contains the required amino acid of abundant cellular metabolism, can improve the living environment of Skin Cell, promotes the metabolism of skin histology.CPP CPP is under neutral and alkali condition, in infants, pass through silk ammonia phosphoric acid and metal ion combinations such as calcium, iron, discharge again after absorbing by small intestine intestines wall, thereby avoided calcium to precipitate the absorption of promotion calcium, iron in the neutral and slight alkali environment effectively at small intestine.
This product adds the peptide of three kinds of combinations simultaneously based on baby milk powder, can strengthen to cut open newborn baby's immunologic function, strengthens the resistance of infant to disease; Improve infant's digestive function, promote intestinal mucosa propagation and improve digestive function; Promote nervous system development to ensure the nervous system nutrition supply, improve infant's memory and learning ability.
Four, the specific embodiment
Present embodiment is intended to explain invention; can not be interpreted as limiting the scope of the invention; floating slightly not as the embodiment of the invention and the inconsistent reason of specification on any nutritional labeling value that causes because of the difference in milk source the invention is intended to protect the nutriment that is added.
Embodiment 1
Product of the present invention is designed to the three phases product according to the difference of infant's all ages and classes stage nutritional need; wherein 1 section is applicable to 0-6 month baby; 2 sections are applicable to 6-12 month big baby; 3 sections are applicable to 1-3 one full year of life child; to produce one ton of product of the present invention is example; its batching is as follows: 1 section product: nonreactive fresh milk: 2050Kg; desalted whey powder 500Kg; but like the compound special oil 170Kg of fourth; anhydrous butter oil 20Kg; FOS (FOS) 10.53Kg (95%); galactooligosaccharide (GOS) 22.5Kg (45%); lactose 3Kg; whey protein peptide 2.89Kg (active ingredient 80%; be 2.31Kg); collagen peptide 1.16Kg (active ingredient 90%, i.e. 1.04Kg); CPP 1.98Kg; DHA 2.98Kg (6.7%); arachidonic acid 2.09Kg (9.6%); soybean lecithin 2Kg; choline 0.75Kg; taurine 0.39Kg; lactoferrin 0.3Kg; inositol 0.23Kg; L-carnitine 0.1Kg; five kinds of nucleotides 0.2Kg; lutein 1.8g; 15'-dioxygenase g (10%); folic acid 0.9g; B B-complex and complex mineral element 4.4Kg; banana end 0.5Kg; apple end 0.5Kg.
2 sections products: nonreactive fresh milk: 3300Kg; desalted whey powder 370Kg; concentrated whey protein powder (protein content 70%) 25Kg; but like the compound special oil 110Kg of fourth; lactose 30Kg; glucose 10Kg; FOS (FOS) 10.53Kg (95%); galactooligosaccharide (GOS) 22.5Kg (45%); whey protein peptide 3.46Kg (active ingredient 80%; be 2.77Kg); collagen peptide 1.38Kg (active ingredient 90%, i.e. 1.24Kg); CPP 1.98Kg; DHA 2.98Kg (6.7%); arachidonic acid 2.09Kg (9.6%); soybean lecithin 2Kg; lactoferrin 0.3Kg; choline 0.7Kg; taurine 0.35Kg; inositol 0.22Kg; L-carnitine 0.11Kg; five kinds of nucleotides 0.2Kg; lutein 1.9g; 15'-dioxygenase g (10%); folic acid 0.9g; B B-complex and complex mineral element 3.86Kg; banana end 0.5Kg; apple end 0.5Kg.
3 sections products: nonreactive fresh milk: 3300Kg; desalted whey powder 370Kg; concentrated whey protein powder (protein content 70%) 25Kg; but like the compound special oil 110Kg of fourth; lactose 25Kg; glucose 10Kg; FOS (FOS) 10.53kg (95%); galactooligosaccharide (GOS) 22.5kg (45%); whey protein peptide 7.03Kg (active ingredient 80%; be 5.62Kg); collagen peptide 2.81Kg (active ingredient 90%, i.e. 2.53Kg); CPP 1.98Kg; DHA 2.98Kg (6.7%); arachidonic acid 2.09Kg (9.6%); soybean lecithin 2Kg; lactoferrin 0.3Kg; choline 0.7Kg; taurine 0.35Kg; inositol 0.22Kg; L-carnitine 0.11Kg; five kinds of nucleotides 0.2Kg; lutein 1.9g; 15'-dioxygenase g (10%); folic acid 0.9g; B B-complex and complex mineral element 3.86Kg; banana end 0.5Kg; apple end 0.5Kg.
Embodiment 2
1 section product: nonreactive fresh milk: 2060Kg; desalted whey powder 500Kg; but like the compound special oil 165Kg of fourth; anhydrous butter oil 24Kg; FOS (FOS) 10.53Kg (95%); galactooligosaccharide (GOS) 22.5Kg (45%); lactose 3Kg; whey protein peptide 2.89Kg (active ingredient 80%; be 2.31Kg); collagen peptide 1.16Kg (active ingredient 90%, i.e. 1.04Kg); CPP 1.98Kg; DHA 2.98Kg (6.7%); arachidonic acid 2.09Kg (9.6%); soybean lecithin 2Kg; choline 0.75Kg; taurine 0.39Kg; lactoferrin 0.3Kg; inositol 0.23Kg; L-carnitine 0.1Kg; five kinds of nucleotides 0.2Kg; lutein 1.8g; 15'-dioxygenase g (10%); folic acid 0.9g; B B-complex and complex mineral element 4.4Kg; banana end 0.5Kg; apple end 0.5Kg.
2 sections products: nonreactive fresh milk: 3260Kg; desalted whey powder 373Kg; concentrated whey protein powder (protein content 70%) 28Kg; but like the compound special oil 110Kg of fourth; lactose 30Kg; glucose 10Kg; FOS (FOS) 10.53Kg (95%); galactooligosaccharide (GOS) 22.5Kg (45%); whey protein peptide 3.46Kg (active ingredient 80%; be 2.77Kg); collagen peptide 1.38Kg (active ingredient 90%, i.e. 1.24Kg); CPP 1.98Kg; DHA 2.98Kg (6.7%); arachidonic acid 2.09Kg (9.6%); soybean lecithin 2Kg; lactoferrin 0.3Kg; choline 0.7Kg; taurine 0.35Kg; inositol 0.22Kg; L-carnitine 0.11Kg; five kinds of nucleotides 0.2Kg; lutein 1.9g; 15'-dioxygenase g (10%); folic acid 0.9g; B B-complex and complex mineral element 3.86Kg; banana end 0.5Kg; apple end 0.5Kg.
3 sections products: nonreactive fresh milk: 3245Kg; desalted whey powder 375Kg; concentrated whey protein powder (protein content 70%) 26Kg; but like the compound special oil 112Kg of fourth; lactose 25Kg; glucose 10Kg; FOS (FOS) 10.53kg (95%); galactooligosaccharide (GOS) 22.5kg (45%); whey protein peptide 7.03Kg (active ingredient 80%; be 5.62Kg); collagen peptide 2.81Kg (active ingredient 90%, i.e. 2.53Kg); CPP 1.98Kg; DHA 2.98Kg (6.7%); arachidonic acid 2.09Kg (9.6%); soybean lecithin 2Kg; lactoferrin 0.3Kg; choline 0.7Kg; taurine 0.35Kg; inositol 0.22Kg; L-carnitine 0.11Kg; five kinds of nucleotides 0.2Kg; lutein 1.9g; 15'-dioxygenase g (10%); folic acid 0.9g; B B-complex and complex mineral element 3.86Kg; banana end 0.5Kg; apple end 0.5Kg.
Embodiment 3
1 section product: nonreactive fresh milk: 2020Kg; desalted whey powder 510Kg; but like the compound special oil 173Kg of fourth; anhydrous butter oil 15Kg; FOS (FOS) 10.53Kg (95%); galactooligosaccharide (GOS) 22.5Kg (45%); lactose 3Kg; whey protein peptide 2.89Kg (active ingredient 80%; be 2.31Kg); collagen peptide 1.16Kg (active ingredient 90%, i.e. 1.04Kg); CPP 1.98Kg; DHA 2.98Kg (6.7%); arachidonic acid 2.09Kg (9.6%); soybean lecithin 2Kg; choline 0.75Kg; taurine 0.39Kg; lactoferrin 0.3Kg; inositol 0.23Kg; L-carnitine 0.1Kg; five kinds of nucleotides 0.2Kg; lutein 1.8g; 15'-dioxygenase g (10%); folic acid 0.9g; B B-complex and complex mineral element 4.4Kg; banana end 0.5Kg; apple end 0.5Kg.
2 sections products: nonreactive fresh milk: 3250Kg; desalted whey powder 375Kg; concentrated whey protein powder (protein content 70%) 26Kg; but like the compound special oil 110Kg of fourth; lactose 30Kg; glucose 10Kg; FOS (FOS) 10.53Kg (95%); galactooligosaccharide (GOS) 22.5Kg (45%); whey protein peptide 3.46Kg (active ingredient 80%; be 2.77Kg); collagen peptide 1.38Kg (active ingredient 90%, i.e. 1.24Kg); CPP 1.98Kg; DHA 2.98Kg (6.7%); arachidonic acid 2.09Kg (9.6%); soybean lecithin 2Kg; lactoferrin 0.3Kg; choline 0.7Kg; taurine 0.35Kg; inositol 0.22Kg; L-carnitine 0.11Kg; five kinds of nucleotides 0.2Kg; lutein 1.9g; 15'-dioxygenase g (10%); folic acid 0.9g; B B-complex and complex mineral element 3.86Kg; banana end 0.5Kg; apple end 0.5Kg.
3 sections products: nonreactive fresh milk: 3330Kg; desalted whey powder 365Kg; concentrated whey protein powder (protein content 70%) 25Kg; but like the compound special oil 110Kg of fourth; lactose 24Kg; glucose 14Kg; FOS (FOS) 10.53kg (95%); galactooligosaccharide (GOS) 22.5kg (45%); whey protein peptide 7.03Kg (active ingredient 80%; be 5.62Kg); collagen peptide 2.81Kg (active ingredient 90%, i.e. 2.53Kg); CPP 1.98Kg; DHA 2.98Kg (6.7%); arachidonic acid 2.09Kg (9.6%); soybean lecithin 2Kg; lactoferrin 0.3Kg; choline 0.7Kg; taurine 0.35Kg; inositol 0.22Kg; L-carnitine 0.11Kg; five kinds of nucleotides 0.2Kg; lutein 1.9g; 15'-dioxygenase g (10%); folic acid 0.9g; B B-complex and complex mineral element 3.86Kg; banana end 0.5Kg; apple end 0.5Kg.
Claims (9)
1. baby formula milk powder, contain the nutritional labeling such as protein, fat, carbohydrate, vitamin, mineral element of infant food national standard defined content in this formula milk, it is characterized in that: also added whey protein peptide, collagen peptide and three kinds of active peptides of CPP in this milk powder.
2. baby formula milk powder as claimed in claim 1 is characterized in that: the addition to 0-6 1 section (body weight 3.14-7.27Kg) whey protein peptide of month baby and collagen peptide active ingredient is respectively 2.31Kg/ ton and 1.04Kg/ ton; 6-12 month addition than big 2 sections (body weight 7.77-8.69Kg) whey protein peptides of baby and collagen peptide active ingredient is respectively 2.77Kg/ ton and 1.24Kg/ ton; Addition to 3 sections (body weight 11.46-13.21Kg) whey protein peptides of 1-3 one full year of life child and collagen peptide active ingredient is respectively 5.62Kg/ ton and 2.53Kg/ ton; CPP determines that according to regulation and three kinds of combined peptide composite effects of GB2760 best auxiliary addition is 0.198g/100g.
3. baby formula milk powder as claimed in claim 2, it is characterized in that: also further contain in this formula milk and can help the digesting and assimilating of infant's body fat, diarrhoea is had the medium chain fatty acid of mitigation, medium chain fatty acid content accounts for about 7.9% of TFA.
4. baby formula milk powder as claimed in claim 3 is characterized in that: lactalbumin and casein ratio are 6: 4, and described lactalbumin derives from nonreactive fresh milk, desalted whey powder, WPC or sepg whey albumen.
5. baby formula milk powder as claimed in claim 4; it is characterized in that: combination of prebiotics FOS and galactooligosaccharide addition are 1g/100g in this 1 section (0-6 month) formula milk; soybean lecithin content is 0.2g/100g; DHA and ARA addition are 20mg/100g; the choline addition is 75mg/100g; the taurine addition is 39mg/100g; the inositol addition is 23mg/100g; L-carnitine addition is 10mg/100g; the lutein addition is 0.18mg/100g, and the beta carotene addition is 0.15mg/100g.
6. baby formula milk powder as claimed in claim 5 is characterized in that: further added lactoferrin and nucleotides in this formula milk, wherein lactoferrin is 30mg/100g; Kind and proportioning that nucleotides adds are cytidine 5 '-phosphate: adenosine 5 '-phosphate: uridine 5 '-phosphate: guanosine 5 '-phosphate: inosine 5 '-phosphate=2: 1: 1: 1: 1.
7. baby formula milk powder as claimed in claim 1 or 2, it is characterized in that: the vegetable oil that adds in the above-mentioned formula milk is one or more linoleic acid, the linolenic combination in soybean salad oil, coconut oil, corn oil and the sunflower oil, has also added anhydrous butter oil in the described in addition milk powder.
8. require described baby formula milk powder as claim 7, it is characterized in that: added banaina and apple end in the described milk powder.
9. as any baby formula milk powder among the claim 1-8, its concrete processing step is as follows:
1) fresh milk is checked and accepted:
Detect as acidity, proportion, taste smell, mingle etc. at every index that may influence product quality, contain harmful substance such as residues of pesticides, antibiotic etc. in the strict control milk human body.
2) raw milk preliminary treatment:
Cow's milk is removed big foreign matter, impurity through the coarse filtration of filter, then 6500 rev/mins down through the processing of centrifugal milk clarifier, remove tiny dust, big bacterial body, body cell etc., make its impurity degree≤0.5mg/Kg, improve the quality of products; Laggard column criterionization makes its composition stable homogeneous, and after chip refrigeration makes the raw material cooling storage temperature≤4 ℃.
3) preheating sterilization:
Raw milk is clung to formula sterilization 15-30 second under 73-80 ℃, to reach kill pathogenic bacteria and most of microorganism, improve the purposes such as heat endurance of cow's milk protein.
4) batching:
Milk after the preheating sterilization is pumped into material-compound tank, except that some vegetable oil and other material dissolution homogeneous that is difficult for mixing are added the material-compound tank, with whey protein peptide, collagen peptide and CPP pump into mixing tank 50-60 ℃ of dissolving down after homogeneous under the 150-180MPa pressure is complete.
With about 45 ℃ water and PURE WHEY, lactose, lactoferrin, choline, inositol, lutein add material-compound tank after restoring evenly.
With small powders such as the abundant dissolution of minerals salt of 30-50 ℃ water, stir, pour the semi-finished product cylinder after the filtration slowly into, the semi-finished product cylinder must not stop when milk is arranged stirring.
Fully dissolve small powders such as vitamin with 30-50 ℃ water, stir, pour the semi-finished product cylinder after the filtration slowly into, the semi-finished product cylinder must not stop when milk is arranged stirring.
5) vacuum concentrates:
Adopt the triple effect evaporation vacuum to concentrate, one imitates vacuum pressure 0.06MPa, and evaporating temperature is 68-72 ℃; Two imitate vacuum 0.08-0.09MPa, triple effect vacuum 0.08-0.09MPa, evaporating temperature 45-50 ℃; After vacuum concentrates, increase the milk powder granularity, improve the milk powder wettable.
6) spraying and dry:
Concentrate breast and be dispersed into tiny vaporific droplet through atomizer in drying tower, tiny droplet mixes (EAT 170-195 ℃) with hot-air, and moisture moment is evaporated, and is discharged by exhaust blower, and temperature of outgoing air 75-90 ℃, the interior negative pressure 5mmH of tower
2About Oh, adopt fluid bed to fail powder and two-stage drying at last.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201010000824A CN101744054A (en) | 2010-01-18 | 2010-01-18 | Infant formula milk powder |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201010000824A CN101744054A (en) | 2010-01-18 | 2010-01-18 | Infant formula milk powder |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101744054A true CN101744054A (en) | 2010-06-23 |
Family
ID=42472132
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201010000824A Pending CN101744054A (en) | 2010-01-18 | 2010-01-18 | Infant formula milk powder |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101744054A (en) |
Cited By (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101946826A (en) * | 2010-07-02 | 2011-01-19 | 美国Youth-base制药国际有限公司 | Formula milk for baby and children with food preference and production method thereof |
| CN101984836A (en) * | 2010-09-06 | 2011-03-16 | 浙江贝因美科工贸股份有限公司 | Method for producing novel infant formula milk powder |
| CN102144668A (en) * | 2011-02-25 | 2011-08-10 | 宝鸡市爱能特营养乳品有限公司 | Infant formula goat milk powder and preparation method thereof |
| CN102715239A (en) * | 2012-07-09 | 2012-10-10 | 澳优乳业（中国）有限公司 | Small peptide high-protein milk powder for children and preparation method thereof |
| CN102763727A (en) * | 2012-07-02 | 2012-11-07 | 李晓林 | Dairy cattle and goat milk composite infant formula milk powder |
| CN102845536A (en) * | 2011-06-27 | 2013-01-02 | 许德建 | Newborn immune formula milk powder |
| CN103005465A (en) * | 2012-12-28 | 2013-04-03 | 福格森（武汉）生物科技有限公司 | Preparation for enhancing nutrition of pregnant women and brain health care of children |
| US20130095204A1 (en) * | 2011-10-14 | 2013-04-18 | Zeina Jouni | Nutritional phytonutrient compositions |
| CN103392812A (en) * | 2013-07-29 | 2013-11-20 | 上海优幼母婴用品有限公司 | Infant formula milk powder specially designed for baby girls |
| CN103392810A (en) * | 2013-07-18 | 2013-11-20 | 河北国绿食生物科技有限公司 | Humanized dairy product and preparation method thereof |
| CN103404595A (en) * | 2013-07-29 | 2013-11-27 | 上海优幼母婴用品有限公司 | Dedicated infant formula for infant boys |
| CN103442592A (en) * | 2010-12-29 | 2013-12-11 | Mjn美国控股有限责任公司 | Use of nutritional compositions including lactoferrin in stimulating immune cells |
| CN103478261A (en) * | 2013-08-26 | 2014-01-01 | 黑龙江省乳品工业技术开发中心 | Baby formula |
| CN103609709A (en) * | 2012-12-04 | 2014-03-05 | 内蒙古伊利实业集团股份有限公司 | Milk powder favorable for sleep and preparation method thereof |
| CN103621685A (en) * | 2013-12-05 | 2014-03-12 | 刘保惠 | Special medical infant formula milk powder with yak milk and preparation method thereof |
| CN104222314A (en) * | 2013-06-24 | 2014-12-24 | 北安宜品努卡乳业有限公司 | Milk powder of immune formula |
| CN104255943A (en) * | 2014-08-29 | 2015-01-07 | 黑龙江飞鹤乳业有限公司 | Method for producing infant formula milk powder from desalted whey liquid |
| CN104351349A (en) * | 2014-11-10 | 2015-02-18 | 江西师范大学 | Preparation method of hypoallergenic infant formula milk powder |
| CN104757123A (en) * | 2015-04-03 | 2015-07-08 | 长沙素加营养品有限公司 | Full dry-mixing infant formula milk powder and preparation method of full dry-mixing infant formula milk powder |
| CN105638908A (en) * | 2016-03-31 | 2016-06-08 | 东北农业大学 | Formula milk powder for infants of 0-6 months and capable of preventing lactose intolerance and protein allergy |
| CN105831284A (en) * | 2016-03-31 | 2016-08-10 | 东北农业大学 | Lactose intolerance and protein allergy preventing formula milk powder for older infants of 6-12 months |
| CN105831254A (en) * | 2016-03-31 | 2016-08-10 | 东北农业大学 | Lactose intolerance and protein allergy preventing formula milk powder for children of 12-36 months |
| CN105994680A (en) * | 2016-05-16 | 2016-10-12 | 北安宜品努卡乳业有限公司 | Infant formula goat milk powder and preparation method thereof |
| CN106578094A (en) * | 2016-12-31 | 2017-04-26 | 东北农业大学 | Old-aged formula milk powder for preventing osteoporosis |
| WO2018028646A1 (en) * | 2016-08-11 | 2018-02-15 | 宏乐集团有限公司 | Powdered milk formula containing peptide for middle-aged and elderly people and preparing method therefor |
| CN107927196A (en) * | 2017-12-11 | 2018-04-20 | 哈尔滨商业大学 | The preparation method of lactoprotein hydrolysis Infant Formula Enterprises with proliferation of probiotics effect |
| US9968123B2 (en) | 2014-03-26 | 2018-05-15 | Abbott Laboratories | Nutritional supplement powder |
| CN108741094A (en) * | 2018-06-08 | 2018-11-06 | 沈阳润东生物科技有限公司 | The newborn polynary zinc of peptide |
| CN108783463A (en) * | 2018-06-08 | 2018-11-13 | 沈阳润东生物科技有限公司 | Newborn peptide Multidimensional Comprehensive nutrition packet |
| CN108936685A (en) * | 2018-06-08 | 2018-12-07 | 沈阳润东生物科技有限公司 | The newborn polynary iron of peptide |
| CN109007843A (en) * | 2018-06-08 | 2018-12-18 | 沈阳润东生物科技有限公司 | The newborn polynary calcium of peptide |
| CN109845826A (en) * | 2019-01-25 | 2019-06-07 | 上海花冠营养乳品有限公司 | An infant milk powder that simulates the structure and composition of breast milk fatty acids |
| CN111543486A (en) * | 2020-06-02 | 2020-08-18 | 陕西恒生乳业有限公司 | Preparation method of milk powder containing lactoferrin and milk powder |
| US10912323B2 (en) | 2016-02-29 | 2021-02-09 | Abbott Laboratories | Nutritional supplement powder |
| CN113331258A (en) * | 2021-07-07 | 2021-09-03 | 林光华 | Novel milk powder formula for accelerating metabolism reaction of children and preparation method thereof |
| CN113455547A (en) * | 2021-07-07 | 2021-10-01 | 林光华 | Formula milk powder for promoting growth and development of children and preparation method thereof |
| CN115590198A (en) * | 2022-09-26 | 2023-01-13 | 黑龙江飞鹤乳业有限公司（Cn） | Use of nucleotide, nutritional composition, food and use thereof |
| WO2023236860A1 (en) * | 2022-06-06 | 2023-12-14 | N.V. Nutricia | Lutein for use in inhibiting mast cell degranulation |
| CN119366561A (en) * | 2024-12-27 | 2025-01-28 | 内蒙古伊利实业集团股份有限公司 | A nutritional composition and its application in enhancing and/or improving individual social behavior |
-
2010
- 2010-01-18 CN CN201010000824A patent/CN101744054A/en active Pending
Cited By (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101946826A (en) * | 2010-07-02 | 2011-01-19 | 美国Youth-base制药国际有限公司 | Formula milk for baby and children with food preference and production method thereof |
| CN101984836A (en) * | 2010-09-06 | 2011-03-16 | 浙江贝因美科工贸股份有限公司 | Method for producing novel infant formula milk powder |
| CN101984836B (en) * | 2010-09-06 | 2013-02-27 | 浙江贝因美科工贸股份有限公司 | Method for producing novel infant formula milk powder |
| CN103442592A (en) * | 2010-12-29 | 2013-12-11 | Mjn美国控股有限责任公司 | Use of nutritional compositions including lactoferrin in stimulating immune cells |
| CN102144668A (en) * | 2011-02-25 | 2011-08-10 | 宝鸡市爱能特营养乳品有限公司 | Infant formula goat milk powder and preparation method thereof |
| CN102845536A (en) * | 2011-06-27 | 2013-01-02 | 许德建 | Newborn immune formula milk powder |
| TWI617247B (en) * | 2011-10-14 | 2018-03-11 | 美強生營養品美國控股公司 | Nutritional phytonutrient compositions |
| US20130095204A1 (en) * | 2011-10-14 | 2013-04-18 | Zeina Jouni | Nutritional phytonutrient compositions |
| CN102763727A (en) * | 2012-07-02 | 2012-11-07 | 李晓林 | Dairy cattle and goat milk composite infant formula milk powder |
| CN102763727B (en) * | 2012-07-02 | 2014-02-19 | 李晓林 | Dairy cattle and goat milk composite infant formula milk powder |
| CN102715239A (en) * | 2012-07-09 | 2012-10-10 | 澳优乳业（中国）有限公司 | Small peptide high-protein milk powder for children and preparation method thereof |
| CN103609709A (en) * | 2012-12-04 | 2014-03-05 | 内蒙古伊利实业集团股份有限公司 | Milk powder favorable for sleep and preparation method thereof |
| CN103005465A (en) * | 2012-12-28 | 2013-04-03 | 福格森（武汉）生物科技有限公司 | Preparation for enhancing nutrition of pregnant women and brain health care of children |
| CN103005465B (en) * | 2012-12-28 | 2014-03-26 | 福格森（武汉）生物科技股份有限公司 | Preparation for enhancing nutrition of pregnant women and brain health care of children |
| CN104222314A (en) * | 2013-06-24 | 2014-12-24 | 北安宜品努卡乳业有限公司 | Milk powder of immune formula |
| CN103392810A (en) * | 2013-07-18 | 2013-11-20 | 河北国绿食生物科技有限公司 | Humanized dairy product and preparation method thereof |
| CN103404595B (en) * | 2013-07-29 | 2015-04-15 | 北安宜品努卡乳业有限公司 | Dedicated infant formula for infant boys |
| CN103404595A (en) * | 2013-07-29 | 2013-11-27 | 上海优幼母婴用品有限公司 | Dedicated infant formula for infant boys |
| CN103392812A (en) * | 2013-07-29 | 2013-11-20 | 上海优幼母婴用品有限公司 | Infant formula milk powder specially designed for baby girls |
| CN103478261A (en) * | 2013-08-26 | 2014-01-01 | 黑龙江省乳品工业技术开发中心 | Baby formula |
| CN103621685A (en) * | 2013-12-05 | 2014-03-12 | 刘保惠 | Special medical infant formula milk powder with yak milk and preparation method thereof |
| CN103621685B (en) * | 2013-12-05 | 2015-02-04 | 刘保惠 | Special medical infant formula milk powder with yak milk and preparation method thereof |
| US10595553B2 (en) | 2014-03-26 | 2020-03-24 | Abbott Laboratories | Nutritional supplement powder |
| US9968123B2 (en) | 2014-03-26 | 2018-05-15 | Abbott Laboratories | Nutritional supplement powder |
| CN104255943A (en) * | 2014-08-29 | 2015-01-07 | 黑龙江飞鹤乳业有限公司 | Method for producing infant formula milk powder from desalted whey liquid |
| CN104351349A (en) * | 2014-11-10 | 2015-02-18 | 江西师范大学 | Preparation method of hypoallergenic infant formula milk powder |
| CN104757123A (en) * | 2015-04-03 | 2015-07-08 | 长沙素加营养品有限公司 | Full dry-mixing infant formula milk powder and preparation method of full dry-mixing infant formula milk powder |
| US10912323B2 (en) | 2016-02-29 | 2021-02-09 | Abbott Laboratories | Nutritional supplement powder |
| CN105638908A (en) * | 2016-03-31 | 2016-06-08 | 东北农业大学 | Formula milk powder for infants of 0-6 months and capable of preventing lactose intolerance and protein allergy |
| CN105831254A (en) * | 2016-03-31 | 2016-08-10 | 东北农业大学 | Lactose intolerance and protein allergy preventing formula milk powder for children of 12-36 months |
| CN105831284A (en) * | 2016-03-31 | 2016-08-10 | 东北农业大学 | Lactose intolerance and protein allergy preventing formula milk powder for older infants of 6-12 months |
| CN105994680A (en) * | 2016-05-16 | 2016-10-12 | 北安宜品努卡乳业有限公司 | Infant formula goat milk powder and preparation method thereof |
| WO2018028646A1 (en) * | 2016-08-11 | 2018-02-15 | 宏乐集团有限公司 | Powdered milk formula containing peptide for middle-aged and elderly people and preparing method therefor |
| CN106578094A (en) * | 2016-12-31 | 2017-04-26 | 东北农业大学 | Old-aged formula milk powder for preventing osteoporosis |
| CN107927196A (en) * | 2017-12-11 | 2018-04-20 | 哈尔滨商业大学 | The preparation method of lactoprotein hydrolysis Infant Formula Enterprises with proliferation of probiotics effect |
| CN108741094A (en) * | 2018-06-08 | 2018-11-06 | 沈阳润东生物科技有限公司 | The newborn polynary zinc of peptide |
| CN108783463A (en) * | 2018-06-08 | 2018-11-13 | 沈阳润东生物科技有限公司 | Newborn peptide Multidimensional Comprehensive nutrition packet |
| CN108936685A (en) * | 2018-06-08 | 2018-12-07 | 沈阳润东生物科技有限公司 | The newborn polynary iron of peptide |
| CN109007843A (en) * | 2018-06-08 | 2018-12-18 | 沈阳润东生物科技有限公司 | The newborn polynary calcium of peptide |
| CN109845826B (en) * | 2019-01-25 | 2022-01-28 | 上海花冠营养乳品有限公司 | Baby milk powder simulating breast milk fatty acid structure and composition |
| CN109845826A (en) * | 2019-01-25 | 2019-06-07 | 上海花冠营养乳品有限公司 | An infant milk powder that simulates the structure and composition of breast milk fatty acids |
| CN111543486A (en) * | 2020-06-02 | 2020-08-18 | 陕西恒生乳业有限公司 | Preparation method of milk powder containing lactoferrin and milk powder |
| CN113455547A (en) * | 2021-07-07 | 2021-10-01 | 林光华 | Formula milk powder for promoting growth and development of children and preparation method thereof |
| CN113331258A (en) * | 2021-07-07 | 2021-09-03 | 林光华 | Novel milk powder formula for accelerating metabolism reaction of children and preparation method thereof |
| WO2023236860A1 (en) * | 2022-06-06 | 2023-12-14 | N.V. Nutricia | Lutein for use in inhibiting mast cell degranulation |
| CN115590198A (en) * | 2022-09-26 | 2023-01-13 | 黑龙江飞鹤乳业有限公司（Cn） | Use of nucleotide, nutritional composition, food and use thereof |
| WO2024067345A1 (en) * | 2022-09-26 | 2024-04-04 | 黑龙江飞鹤乳业有限公司 | Use of nucleotide, nutritional composition, food product, and use thereof |
| CN115590198B (en) * | 2022-09-26 | 2024-06-18 | 黑龙江飞鹤乳业有限公司 | Use of nucleotide, nutritional composition, food and use thereof |
| CN119366561A (en) * | 2024-12-27 | 2025-01-28 | 内蒙古伊利实业集团股份有限公司 | A nutritional composition and its application in enhancing and/or improving individual social behavior |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101744054A (en) | Infant formula milk powder | |
| CN103621633B (en) | Infant series yak milk formula milk powder and preparation method thereof | |
| CN101015361B (en) | Instant sea cucumber dissolved granule and its preparing process | |
| CN101530195B (en) | A special dietary food formula containing short peptides for puerpera | |
| CN103651940B (en) | Yak milk formula milk powder for middle and old age, and preparation method thereof | |
| CN102356798B (en) | Milk calcium candy and preparation method thereof | |
| CN103621685B (en) | Special medical infant formula milk powder with yak milk and preparation method thereof | |
| KR101861333B1 (en) | Nutrition jelly for pets and manufacturing method of the same | |
| CN101496576B (en) | A special dietary food formula containing short peptides for patients with bone injuries | |
| CN105360319A (en) | Child development formula milk powder and preparation method thereof | |
| CN104161222A (en) | Milking sow feed | |
| CN104982937B (en) | It is a kind of to promote sclerotin and the composition of periosteum for repairing and preparation method thereof | |
| CN100998368A (en) | Protein powder produced by fluidized bed spraying lecithinum granulation technique and preparing method thereof | |
| CN104920618A (en) | Formula goat milk powder for pregnant and lying-in woman | |
| CN103960530A (en) | Ecological feed for conventional black pig fattening period under stocking condition | |
| CN104799281A (en) | Method for producing compound peanut milk suitable for old people | |
| CN108703365A (en) | Protein allergy tailored version clinical nutrition formula and preparation method thereof | |
| CN108013452A (en) | A kind of puerperal abdominal flatulence gas tailored version clinical nutrition formula and preparation method thereof | |
| CN107536021A (en) | A kind of fortification albumen composite powder and preparation method thereof | |
| CN111587923A (en) | An infant formula containing sialic acid and its preparation method | |
| CN101279089A (en) | Donkey-hide gelatin calcium composition and preparing process thereof | |
| CN110074189A (en) | A kind of infant's diatery supplement and preparation method thereof adding human milk oligosaccharides | |
| CN103976248A (en) | Infant milk calcium rice flour and preparation method thereof | |
| CN107751604A (en) | A kind of low-temperature water-soluble piglet opened guideway and its manufacture craft | |
| CN117481199A (en) | Premature/low birth weight infant food that promotes growth and development and preparation method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20100623 |